
Royal Street Ventures
3100 Pinebrook Rd., Suite 2100, Park City, UT, 84098, United States
Overview
Royal Street Ventures is a seed stage VC fund, investing in companies from the Midwest to the Pacific U.S.
- Total investments
- 25
- Lead investments
- 3
- Investments · 12mo
- 1
- Active investors
- 2
Investment portfolio
- Inhouse
Participated · Seed · Mar 2026
Inhouse provides an artificial-intelligence legal platform that executes substantive legal tasks for small and midsize businesses. The system blends proprietary AI software with an affiliated law firm and a nationwide network of licensed attorneys, enabling users to draft contracts, resolve complex legal questions, and seamlessly consult human counsel when necessary. Current product capabilities cover contract lifecycle management, compliance workflows, and proactive risk management. The company also maintains partnerships with prominent national law firms, including Baker Hostetler, Morgan & Morgan, and Imhoff & Associates. With fresh capital, Inhouse plans to deepen its AI agent functionality and further automate key legal processes. Co-founders Ryan Wenger and Aarshay Jain lead the Los Angeles-based venture as it seeks to modernize legal services for growing companies.
- Abett
Participated · Series A · May 2024
Abett builds a software platform that helps large employers manage and analyze health plan data. Its Lockbox product enables benefits teams to share, store and analyze plan data to identify cost savings by altering benefits. The company raised $11.6 million to grow its software platform. That round was led by Acrew Capital and brings Abett's total funding to $27 million. Abett's stated mission is to increase transparency in the healthcare system—"sunlight is the best disinfectant"—with technology to expose hidden data and drive accountability and better care. The article does not disclose revenue, user metrics, or additional investors.
- Treads
Participated · Seed · Nov 2023
Treads is an AI-powered car management subscription company that centralizes tire, alignment, oil change, wiper blade, and auto insurance services through a mobile app. The platform uses AI for predictive maintenance alerts and visual machine learning to assess tire repairability and replacement needs from customers' smartphone scans, returning tire size, tread depth, and condition. Customers can have new tires delivered and installed at home or work, and access brick-and-mortar service centers in the Treads Service Network. The company raised $4.6M in seed funding to support growth. Led by CEO and Founder Zach Olson and based in Park City, UT, Treads plans to expand into 16 additional U.S. cities to reach availability in 34 cities by the end of 2023. The funds are intended to support that geographic expansion.
- Paccurate
Participated · Equity · Aug 2023
Paccurate offers cartonization software and an API that determines the most cost-effective and sustainable way to ship items by accounting for size, weight and packaging requirements. The product is used by brands such as Daily Harvest and Our Place and is positioned as a more accurate alternative to embedded cartonization in larger supply‑chain platforms. The founders, James Malley and Patrick Powers, launched the company in 2018 after identifying a persistent packaging‑optimization gap while consulting. Paccurate initially bootstrapped, took a seed round in 2022 amid pandemic-driven demand, and has since scaled rapidly. Operational throughput climbed from about a million shipments a month last year to roughly a million shipments a day today. The company cites regulatory tailwinds (EU rules and proposed U.S. state bills requiring fuller boxes) and a less saturated market segment as drivers for continued growth. Paccurate is a New York-based cartonization platform that suggests the optimal packing methodology for every shipment using patented technology. Its solution accounts for external factors such as labor, material and complex carrier rates to create cost-optimal packing recommendations. The company delivers dynamic, real-time suggestions via a lightweight API designed for quick integration. Paccurate aims to use its recent funding to drive expansion and further develop its solution. The platform currently optimizes more than 1 million shipments per month and has helped customers save millions of dollars in shipping, cardboard and filler costs. The product targets shippers of all sizes and emphasizes reductions in waste, costs, and item damage. Paccurate provides a containerization engine with a lightweight API designed to reduce costs and the carbon impact of the ecommerce supply chain. Led by CEO James Malley, the company serves retailers and 3PLs and has implementations at Hunter Douglas, Crate & Barrel, Dillard’s, and other retailers. In March the company optimized a record 2.7 million shipments. The platform focuses on fulfillment optimization to lower shipping costs and environmental footprint. Paccurate intends to use new funding to onboard major retailers and 3PLs faster and to expand its suite of fulfillment optimization tools. The company recently raised seed funding to support that growth.
- Curavit Clinical Research
Participated · Series A · Nov 2022
Curavit Clinical Research is a Boston-based virtual contract research organization (VCRO) that designs and executes digital-first decentralized clinical trials (DCTs). Led by co-founder and CEO Joel Morse, Curavit is a full-service VCRO focused on prescription and non-prescription digital therapeutics trials. Its digital-first DCTs aim to improve timelines, reduce costs, generate real-world data, and increase patient access across representative populations. The company raised $5 million in a Series A led by Osage Venture Partners with participation from Royal Street Ventures and Narrow Gauge Ventures. The financing adds to early investments from the founders and individual investors, including industry veterans Clark Golestani and Matt Wallach. Curavit intends to use the funds to expand DCT capabilities, partnerships, and market adoption of its virtual CRO services and platform.